Skip to main content
Have a personal or library account? Click to login
Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma Cover

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma

Radiology and Oncology
Volume 48 (2014): Issue 2 (June 2014)
By: ,  ,  ,  ,   and    
Open Access
|Apr 2014
References

References

  1. 1Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2013.
    Search in Google Scholar
  2. 2. Buyukasik O, Hasdemir AO, Gulnerman Y, Col C, Ikiz O. Second primary cancers in patients with gastric cancer. Radiol Oncol 2010;239-43.
    Open DOISearch in Google Scholar
  3. 3. Rajev L. Treatment options for surgically resectable gastric cancer. Curr Treat Options Oncol 2010;14-23.
    Open DOISearch in Google Scholar
  4. 4. Buergy D, Lohn F, Baack T, Siebenlist K, Haneder S, Michaely H, et al. Radiotherapy for tumors of the stomach and gastoesophageal junction - a review of its role in multimodal therapy. Radiat Oncol 2012;192
    Open DOISearch in Google Scholar
  5. 5. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;725-30.
    Open DOISearch in Google Scholar
  6. 6. Oblak I, Velenik V, Anderluh F, Strojan P. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia. Eur J Surg Oncol 2007;982-7.
    Open DOISearch in Google Scholar
  7. 7. Oblak I, Anderluh F, Velenik VPostoperative radiochemotherapy for gastric adenocarcinoma: long term results. Radiol Oncol 2009;274-81.
    Open DOISearch in Google Scholar
  8. 8. Rossi D, Alessandroni P, Catalano V, Giordani P, Fedeli A, Baldelli AM, et al. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer. Clin Breast Cancer 2007;857-60.
    Open DOISearch in Google Scholar
  9. 9. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;23-44.
    Open DOISearch in Google Scholar
  10. 10. Ocvirk J, Rebersek M, Skof E, Hlebanja Z, Boc M. Randomized prospective phase II study to compare the combination chemotherapy regiment epirubicin, cisplatin and 5-fluorouracil with epirubicin, cisplatin and capecitabine in patients with advanced or metastatic gastric cancer. Am J Clin Oncol 2012;237-41.
    Open DOISearch in Google Scholar
  11. 11. Twelves C, Scheithauer W, McKendrick J, Seitz JF, Van Hazel G, Wrong A, et al. Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Ann Oncol 2012;1190-7.
    Open DOISearch in Google Scholar
  12. 12. American Joint Committee on Cancer.7th edition. New York: Springer-Verlag; 2009.
    Search in Google Scholar
  13. 13. Ajani JA, Welch SR, Raber MN, Fiels WS, Krakoff IM. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990;147-59.
    Open DOISearch in Google Scholar
  14. 14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;457-81.
    Open DOISearch in Google Scholar
  15. 15. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;1-39.
    Open DOISearch in Google Scholar
  16. 16. Cox DR. Regression models and life-tables. J R Stat Soc Bull 1972;187-220.
    Open DOISearch in Google Scholar
  17. 17. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. Ca Cancer J Clin 2000;7-33.
    Open DOISearch in Google Scholar
  18. 18. Ajani JA. Chemotherapy for gastric carcinoma: new and old options. Oncology (Huntingt) 1998;44-7.
    Search in Google Scholar
  19. 19. Gunderson LL. Gastric cancer: patterns of relapse after surgical resection. Semin Radiat Oncol 2002;150-61.
    Open DOISearch in Google Scholar
  20. 20. Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, et al. Postoperative chemotherapy for gastric cancer. Ann Oncol 2003;1373-7.
    Open DOISearch in Google Scholar
  21. 21. Kim S, Lim DH, Lee J, Kang WK, McDonald JS, Park CH, et al. An observation study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 2005;1279-85.
    Open DOISearch in Google Scholar
  22. 22. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani Ja, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;2327-33.
    Open DOISearch in Google Scholar
  23. 23. Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 2010;2430-6.
    Open DOISearch in Google Scholar
  24. 24. Lee J, Lim do H, Kim S, Park SH, Park JO, Park YS, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 2012;268-73.
    Open DOISearch in Google Scholar
  25. 25. Zhu WG, Xua DF, Pu J, Zong CD, Li T, Tao GZ, et al. A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection. Radiother Oncol 2012;361-6.
    Open DOISearch in Google Scholar
  26. 26. Yu C, Yu R, Zhu W, Song Y, Li T. Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery. J Cancer Res Clin Oncol 2012;255-9.
    Open DOISearch in Google Scholar
  27. 27. Jansen EP, Boot H, Saunders MP, Crosby TD, Dubbelman R, Bartelink H, et al. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 2007;: 1424-8.
    Open DOISearch in Google Scholar
  28. 28. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998;125-33.
    Open DOISearch in Google Scholar
  29. 29. Orditura M, De Vita F, Muto P, Vitiello F, Murino P, Lieto E, et al. Adjuvant chemotherapy in patients with stage III or IV radically resected gastric cancer. Arch Surg 2010;233-8.
    Open DOISearch in Google Scholar
  30. 30. Yao JC, Mansfield PF, Pisters PWT, Feig BW, Janjan NA, Crane C, et al. Combined modality therapy for gastric cancer. Semin Surg Oncol 2003;223-7.
    Open DOISearch in Google Scholar
  31. 31. Avital I, Pisters PWT, Kelsen DP, Willett CG. Cancer of the stomach. In: DeVita VT, Lawrence TS, Rosenberg SA, editors.9th edition. Philadelphia: Lippincott-Williams &Wilkins; 2004. p. 924-54.
    Search in Google Scholar
  32. 32. Willett CG, Gunderson LL. Stomach. In: Halperin EC, Perez CA, Brady LW, editors.5th edition. Philadelphia: Lippincott-Williams &Wilkins; 2008. p. 1318-35.
    Search in Google Scholar
  33. 33. Chua YJ, Cunningham D. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice. Ann Surg Oncol 2007;2687-90.
    Open DOISearch in Google Scholar
  34. 34. Ikeguchi M, Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer.2004;: 645-8.
    Open DOISearch in Google Scholar
  35. 35. Huang CM, Wang JB, Lu HS, Zheng CH, Li P, Wie JW, et al. Prognostic impact of splenectomy on advanced proximal gastric cancer with No.10 lymph node metastasis. Chin Medl J 2009;2757-62.
    Search in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0065 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 189 - 196
Submitted on: Jun 28, 2013
Accepted on: Aug 13, 2013
Published on: Apr 25, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
gastric cancer,
capecitabine,
adjuvant therapy,
radiochemotherapy,
survival,
toxicity
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2014 Irena Oblak, Marija Skoblar Vidmar, Franc Anderluh, Vaneja Velenik, Ana Jeromen, Jasna But Hadzic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 48 (2014): Issue 2 (June 2014)
Previous article
Next article